<DOC>
	<DOCNO>NCT02950012</DOCNO>
	<brief_summary>The purpose study investigate effect OPTI-BIOME™ ( Bacillus subtilis MB40 ) , probiotic supplement , bloating , gas abdominal discomfort symptom otherwise healthy adult .</brief_summary>
	<brief_title>A Study Evaluate OPTI-BIOME™ Bacillus Subtilis MB40 Abdominal Discomfort , Gas Bloating Healthy Population</brief_title>
	<detailed_description />
	<criteria>1 . Male female 1875 year ( inclusive ) age 2 . BMI 18.529.9 ±1 kg/m2 3 . Abdominal bloating intensity score ≥5 least two day bloat 2 week prior screen ( assessed screen Abdominal Bloating questionnaire ) 4 . Participants categorize 'high bloater ' define average bloat score ≥ 5 runin period assess baseline question 3 Modified Daily Abdominal Discomfort , Gas , Bloating Questionnaire , AND/OR , participant categorize 'high frequency bloater ' define great 7 day high bloating ( define ) runin period . For female , include abdominal discomfort bloating experienced menstruation , symptom occur due menstrual cycle female go another runin period . 5 . If female , participant child bear potential , defined female hysterectomy oophorectomy , bilateral tubal ligation postmenopausal ( natural surgically &gt; 1 year since last menstruation ) OR Females childbearing potential must agree use medically approve method birth control negative urine pregnancy test result . Acceptable method birth control include : Hormonal contraceptive ( stable 1 month ) include oral contraceptive , hormone birth control patch ( Ortho Evra ) , vaginal contraceptive ring ( NuvaRing ) , injectable contraceptive ( DepoProvera , Lunelle ) , hormone implant ( Norplant System ) Doublebarrier method Intrauterine device Nonheterosexual lifestyle agree use contraception planning change heterosexual partner ( ) Vasectomy partner ( show successful per appropriate followup ) 6 . Healthy determine laboratory result , medical history , physical exam 7 . Agrees abstain consume unpasteurized bacteriafermented food include cheese yogurt 1 week prior screen visit throughout study 8 . Agrees abstain use fiber supplement 2 week prior screen duration study 9 . Agrees maintain current dietary habit activity/training level two week prior baseline course study 10 . Agrees avoid probiotic one week prior screen course study 11 . Willingness complete study requirement attend clinic visit . 12 . Has give voluntary , write , inform consent participate study 1 . Females pregnant , breastfeeding , plan become pregnant course trial 2 . History chronic inflammation structural abnormality digestive tract ( inflammatory bowel disease , duodenal gastric ulcer , intestinal obstruction , symptomatic cholelithiasis ) 3 . Nocturnal and/or progressive abdominal pain ( abdominal pain increase intensity consistent regular basis ) 4 . Significant weight loss past 3 month ( significance determine Qualified Investigator ) 5 . Type 1 type 2 diabetes 6 . History colorectal cancer , anal abscess , anal fistula , anal fissure , anal stenosis , gastric retention obstruction , bowel resection , rectocele , colostomy 7 . Cancer except skin cancer complete excised chemotherapy radiation follow negative follow . 8 . Diagnosis adenomatous polyposis , irritable bowel syndrome , chronic gastritis functional dyspepsia , crohn disease , celiac disease Renal hepatic insufficiency 9 . Gastrointestinal bleed acute infection 10 . Immunodeficiency 11 . History organ transplant 12 . Use antibiotic within 4 week randomization Routine ( least 3 time per week ) consumption probiotic prebiotic supplement supplement food unwilling stop least one week prior screen throughout study 13 . Use immunosuppressant drug 14 . Change antipsychotic medication within 3 month randomization 15 . Abdominal surgery within 6 month randomization 16 . Plan donate blood study within 30 day complete study 17 . Participation clinical research trial within 30 day prior randomization 18 . Allergy sensitivity study supplement placebo ingredient 19 . Alcohol abuse ( &gt; 2 standard alcoholic drink per day ) drug abuse within last 6 month 20 . Use Medicinal Marijuana 21 . Cognitively impaired and/or unable give inform consent 22 . Unstable medical condition 23 . Clinically significant abnormal laboratory result screen 24 . Any condition Qualified Investigator 's opinion may adversely affect volunteer 's ability complete study measure may pose significant risk volunteer</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>Healthy</keyword>
	<keyword>Bloating</keyword>
	<keyword>Abdominal Discomfort</keyword>
	<keyword>Gas</keyword>
	<keyword>Probiotic</keyword>
	<keyword>Bacillus Subtillis</keyword>
</DOC>